University of Limerick Institutional Repository

NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease.

DSpace Repository

Show simple item record

dc.contributor.author Lawlor, Brian
dc.contributor.author Kennelly, Sean
dc.contributor.author O'Dwyer, Sarah
dc.contributor.author Cregg, Fiona
dc.contributor.author Walsh, Cathal Dominic
dc.contributor.author Cohen, Robert
dc.contributor.author Kenny, Rose Anne
dc.contributor.author Howard, Robert
dc.contributor.author Murphy, Caroline
dc.contributor.author Adams, Jessica
dc.contributor.author Daly, Leslie
dc.contributor.author Segurado, Ricardo
dc.contributor.author Gaynor, Siobhan
dc.contributor.author Crawford, Fiiona
dc.contributor.author Mullan, Michael
dc.contributor.author Lucca, Ugo
dc.contributor.author Banzi, Rita
dc.contributor.author Pasquier, Florence
dc.contributor.author Breuilh, Laetitia
dc.contributor.author Riepe, Matthias
dc.contributor.author Kalman, Janos
dc.contributor.author Wallin, Anders
dc.contributor.author Borjesson, Anne
dc.contributor.author Molloy, William
dc.contributor.author Tsolaki, Magda
dc.contributor.author Rikkert, Marcel Olde
dc.date.accessioned 2016-02-29T12:53:05Z
dc.date.available 2016-02-29T12:53:05Z
dc.date.issued 2014
dc.identifier.uri http://hdl.handle.net/10344/4922
dc.description peer-reviewed en_US
dc.description.abstract This study is a European multicentre, randomised, double-blind, placebo-controlled trial investigating the efficacy and safety of nilvadipine as a disease course modifying treatment for mild-tomoderate Alzheimer’s disease (AD) in a phase III study that will run for a period of 82 weeks with a treatment period of 78 weeks en_US
dc.language.iso eng en_US
dc.publisher BMJ Publshing Group en_US
dc.relation info:eu-repo/grantAgreement/EC/FP7/279093 en_US
dc.relation.ispartofseries BMJ Open;4: e006364
dc.subject NILVAD protocol en_US
dc.subject alzheimer's disease en_US
dc.title NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease. en_US
dc.type info:eu-repo/semantics/article en_US
dc.type.supercollection all_ul_research en_US
dc.type.supercollection ul_published_reviewed en_US
dc.date.updated 2016-02-29T12:32:45Z
dc.description.version PUBLISHED
dc.identifier.doi 10.1136/bmjopen-2014-006364
dc.contributor.sponsor ERC en_US
dc.relation.projectid 279093 en_US
dc.rights.accessrights info:eu-repo/semantics/openAccess en_US
dc.internal.rssid 1596307
dc.internal.copyrightchecked Yes
dc.description.status peer-reviewed


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ULIR


Browse

My Account

Statistics